Inhibitex michael kors purses cheap Inc. And Bristol Myers Squibb Co.: INHX, a developer of differentiated anti infective products to prevent and treat serious viral and bacterial infections, including primarily shingles and chronic infections caused by hepatitis C virus, is under agreement to be acquired by BMY, a developer michael kors cheap of branded pharmaceuticals for the treatment of cardiovascular, virological and other infectious diseases. Mega funds cut $28 million in Q3 from a $512 million prior quarter position in INHX, and they added a net $711 million to their $20.51 billion prior quarter position in BMY..
http://www.fursuit.org/node/5914
http://www.impiantissc.it/node/74519
http://bereanstechnology.com/index.php?q=node/47402